No Data
No Data
Abterra Medical (301097.SZ): As of June 7, 2024, the total number of shareholders in the company is 2,896.
On June 11th, Gelonhui reported that as of June 7th, 2024, there were a total of 2,896 shareholders in Abterra Medical (301097.SZ) according to information on the investor interaction platform.
Abterra Medical (301097.SZ) has spent a total of 49.26 million yuan to repurchase 2.05% of its shares.
On June 7th, Gelonhui reported that as of June 5th, 2024, Abterra Medical (301097.SZ) has cumulatively repurchased 1,208,600 shares of the company through a repurchase special securities account in the centralized bidding trading method, accounting for 2.05% of the company's total A-share capital. The highest transaction price was 42.80 yuan per share, the lowest transaction price was 36.99 yuan per share, and the total transaction amount was 49,260,547.00 yuan (excluding transaction costs).
Tianyi Medical (301097.SZ): A total cost of 388.51 million yuan to buy back 954,300 shares of the company
Gelonghui, June 3 | Tianyi Medical (301097.SZ) announced that as of May 31, 2024, the company had repurchased 954,300 shares of the company's shares through centralized bidding transactions through the Shenzhen Stock Exchange stock trading system, accounting for 1.62% of the company's current total share capital. The highest transaction price was 42.75 yuan/share, the minimum transaction price was 36.99 yuan/share, and the total transaction amount was RMB 38,850,976.00 (excluding transaction fees such as stamp duty and transaction fees). This repurchase complies with the requirements of relevant laws and regulations and the company's established repurchase plan.
Tianyi Medical (301097.SZ) plans to spend 43.54 million euros with controlling shareholders and actual controllers to acquire CRRT business owned by NKS
Tianyi Medical (301097.SZ) announced that the company will hold the 3rd 14th Board Meeting on May 31, 2024...
Tianyi Medical (301097.SZ) holding shareholders and actual controllers promise to avoid competition in the industry
Zhitong Finance App News, Tianyi Healthcare (301097.SZ) announced that on May 31, 2024, the company received a “Letter of Commitment on Avoiding Competition” from Wu Zhimin and Wu Bin, the controlling shareholders and actual controllers of the company, to jointly invest with Tianyi Medical to acquire Nikkiso Co in cash. In matters relating to the CRRT business (“target business”) held by Ltd (hereinafter referred to as “NKS”), the controlling shareholders and actual controllers Wu Zhimin and Wu Bin issued a letter of commitment to avoid competition in the industry. The details of the commitment are as follows: 1. Ningbo Tianhuiyi Enterprise Management Limited Liability, which I control
Tianyi Medical (301097.SZ): Plans to increase capital by 60 million yuan to Ningbo Tianhuiyi
Gelonghui, May 31, 丨 Tianyi Medical (301097.SZ) announced that the company held its 3rd 14th board meeting on May 31, 2024 to review and pass the “Proposal on Joint Investment and Related Transactions with Related Parties”, agreeing to increase the capital of Ningbo Tianhuiyi Enterprise Management Co., Ltd. (“Ningbo Tianhuiyi” or “SPVB” for short) by RMB 60 million. After the capital increase is completed, Tianyi Medical will hold 20.87% of Ningbo Tianhuiyi's shares.
No Data